Ignite Creation Date:
2024-05-05 @ 11:35 AM
Last Modification Date:
2024-10-26 @ 9:10 AM
Study NCT ID:
NCT00089557
Status:
TERMINATED
Last Update Posted:
2005-06-24
First Post:
2004-08-06
Brief Title:
An Open-Label Extension Study of NGX-4010 for the Treatment of Neuropathic Pain
Sponsor:
NeurogesX
Organization:
NeurogesX
Study Overview
Official Title:
An Open-Label Extension Study of NGX-4010 for the Treatment of Neuropathic Pain
Status:
TERMINATED
Status Verified Date:
2004-09
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This study is an open-label multicenter extension study for subjects who completed NeurogesX Study C111 and received treatment with NGX-4010 Capsaicin Patch within 12 weeks up to 7days before entry into Study C114
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None